151 related articles for article (PubMed ID: 21516290)
1. The involvement of glycosaminoglycans in airway disease associated with cystic fibrosis.
Reeves EP; Bergin DA; Murray MA; McElvaney NG
ScientificWorldJournal; 2011 Apr; 11():959-71. PubMed ID: 21516290
[TBL] [Abstract][Full Text] [Related]
2. IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis.
Reeves EP; Williamson M; Byrne B; Bergin DA; Smith SG; Greally P; O'Kennedy R; O'Neill SJ; McElvaney NG
J Immunol; 2010 Feb; 184(3):1642-52. PubMed ID: 20026745
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycans are differentially involved in bacterial binding to healthy and cystic fibrosis lung cells.
Martin C; Lozano-Iturbe V; Girón RM; Vazquez-Espinosa E; Rodriguez D; Merayo-Lloves J; Vazquez F; Quirós LM; García B
J Cyst Fibros; 2019 May; 18(3):e19-e25. PubMed ID: 30415947
[TBL] [Abstract][Full Text] [Related]
4. Organ-specific over-sulfation of glycosaminoglycans and altered extracellular matrix in a mouse model of cystic fibrosis.
Hill WG; Harper GS; Rozaklis T; Boucher RC; Hopwood JJ
Biochem Mol Med; 1997 Oct; 62(1):113-22. PubMed ID: 9367807
[TBL] [Abstract][Full Text] [Related]
5. LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline.
Bergsson G; Reeves EP; McNally P; Chotirmall SH; Greene CM; Greally P; Murphy P; O'Neill SJ; McElvaney NG
J Immunol; 2009 Jul; 183(1):543-51. PubMed ID: 19542465
[TBL] [Abstract][Full Text] [Related]
6. Proteases and cystic fibrosis.
Voynow JA; Fischer BM; Zheng S
Int J Biochem Cell Biol; 2008; 40(6-7):1238-45. PubMed ID: 18395488
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in
Schiumarini D; Loberto N; Mancini G; Bassi R; Giussani P; Chiricozzi E; Samarani M; Munari S; Tamanini A; Cabrini G; Lippi G; Dechecchi MC; Sonnino S; Aureli M
Mediators Inflamm; 2017; 2017():1730245. PubMed ID: 29333001
[TBL] [Abstract][Full Text] [Related]
8. Inflammation in cystic fibrosis: An update.
Roesch EA; Nichols DP; Chmiel JF
Pediatr Pulmonol; 2018 Nov; 53(S3):S30-S50. PubMed ID: 29999593
[TBL] [Abstract][Full Text] [Related]
9. Association of Antibiotics, Airway Microbiome, and Inflammation in Infants with Cystic Fibrosis.
Pittman JE; Wylie KM; Akers K; Storch GA; Hatch J; Quante J; Frayman KB; Clarke N; Davis M; Stick SM; Hall GL; Montgomery G; Ranganathan S; Davis SD; Ferkol TW;
Ann Am Thorac Soc; 2017 Oct; 14(10):1548-1555. PubMed ID: 28708417
[TBL] [Abstract][Full Text] [Related]
10. Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease.
Souza-Fernandes AB; Pelosi P; Rocco PR
Crit Care; 2006; 10(6):237. PubMed ID: 17118216
[TBL] [Abstract][Full Text] [Related]
11. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.
Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N
Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645
[TBL] [Abstract][Full Text] [Related]
12. The role of matrix metalloproteinases in cystic fibrosis lung disease.
Gaggar A; Hector A; Bratcher PE; Mall MA; Griese M; Hartl D
Eur Respir J; 2011 Sep; 38(3):721-7. PubMed ID: 21233269
[TBL] [Abstract][Full Text] [Related]
13. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis.
Reeves EP; Williamson M; O'Neill SJ; Greally P; McElvaney NG
Am J Respir Crit Care Med; 2011 Jun; 183(11):1517-23. PubMed ID: 21330456
[TBL] [Abstract][Full Text] [Related]
14. BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization.
Hovold G; Lindberg U; Ljungberg JK; Shannon O; Påhlman LI
Respir Med; 2020; 170():105994. PubMed ID: 32843162
[TBL] [Abstract][Full Text] [Related]
15. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
16. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
[TBL] [Abstract][Full Text] [Related]
17. The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis.
McElvaney OJ; O'Reilly N; White M; Lacey N; Pohl K; Gerlza T; Bergin DA; Kerr H; McCarthy C; O'Brien ME; Adage T; Kungl AJ; Reeves EP; McElvaney NG
Mol Immunol; 2015 Feb; 63(2):550-8. PubMed ID: 25453468
[TBL] [Abstract][Full Text] [Related]
18. Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs.
Makam M; Diaz D; Laval J; Gernez Y; Conrad CK; Dunn CE; Davies ZA; Moss RB; Herzenberg LA; Herzenberg LA; Tirouvanziam R
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5779-83. PubMed ID: 19293384
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway.
Cosgrove S; Chotirmall SH; Greene CM; McElvaney NG
J Biol Chem; 2011 Mar; 286(9):7692-704. PubMed ID: 21193404
[TBL] [Abstract][Full Text] [Related]
20. Airway remodelling and its relationship to inflammation in cystic fibrosis.
Regamey N; Jeffery PK; Alton EW; Bush A; Davies JC
Thorax; 2011 Jul; 66(7):624-9. PubMed ID: 20889525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
